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differentiation process in vivo. Several reports from Mescher’s lab 
demonstrated a role for type I IFNs and IL-12 as the third signal 
required for the enhancement of cytolytic activity and IFN-γ pro-
duction by the naïve OT-I TcR transgenic CD8 T cells responding 
to in vitro stimulation with antigen/MHC class I complexes and B7 
ligands coupled microspheres (Curtsinger et al., 1999, 2003, 2005). 
However, it is unclear how in vitro system relates to complex in vivo 
sensing of infection. For example, CD8 T cells could potentially 
receive multiple inflammatory signals (signal 3) directly from the 
priming dendritic cells (DC) that present the antigen (signal 1) and 
costimulation (signal 2) or they could receive the signal 3 from the 
pathogen-induced systemic inflammatory cytokines after prim-
ing or both. Thus, dissociating the inflammatory signals from the 
activating signal 1 and 2 would provide a better understanding of 
how specific cytokines regulate the commitment of the responding 
CD8 T cells to effector or memory differentiation.
Recent studies suggest that IL-12 signaling directly to CD8 T 
cells enhances expansion, promotes terminal differentiation (Pearce 
and Shen, 2007; Cui et al., 2009), and regulates memory forma-
tion through a gradient of T-bet expression (Joshi et al., 2007). In 
addition, inflammatory cytokines play an important role in regu-
lating the rate at which responding CD8 T cells acquire memory 
phenotype and function (Harty and Badovinac, 2008). Priming of 
CD8 T cells in a low inflammatory environment (i.e., DC immu-
nization) accelerates memory CD8 T cell development (Badovinac 
et al., 2005). As early as 6 or 7 days after priming, the antigen-
specific CD8 T cells exhibit memory characteristics defined by 
IL-7Rα (CD127) and KLRG-1 expression profiles (CD127hiKLRG-
1lo), and the ability to vigorously expand in response to booster 
IntroductIon
The naive CD8 T cell repertoire for any specific pathogen–peptide 
ranges between 10 and 1000 cells per mouse (Blattman et al., 2002). 
In order to combat infection, the pathogen specific CD8 T cells 
must expand in number and acquire effector functions. Following 
an infection, pathogen-induced inflammatory cytokines directly 
modulate all phases of the CD8 T cell response including prolifera-
tion, survival, effector, and memory differentiation (Mescher et al., 
2006; Xiao et al., 2009). In particular, type I interferons (IFN, i.e., 
IFN-α, -β) and IL-12 have been demonstrated to serve as “signal 
3” for optimal CD8 T cell expansion (Haring et al., 2006) and have 
also been implicated in the differentiation of effector CD8 T cells 
(Mescher et al., 2006).
Signal 3 inflammatory cytokines regulate multiple aspects of the 
CD8 T cell response. Interestingly, the specific cytokine serving as 
the signal 3 depends on the pathogen under investigation (Harty 
and Badovinac, 2008). For example, type I IFN signaling in CD8 
T cells is most critical for numerical expansion in the lymphocytic 
choriomeningitis virus infection model, whereas IL-12 serves as the 
critical signal 3 for CD8 T cells responding to Listeria monocytogenes 
(LM) and vaccinia infection (Kolumam et al., 2005; Thompson 
et al., 2006; Xiao et al., 2009). However, it remains unclear if these 
same critical signal 3 inflammatory cytokines also directly regulate 
the commitment of responding CD8 T cells to effector or memory 
differentiation in vivo. While experimental infection models have 
provided crucial insights into the differentiation of antigen-specific 
CD8 T cells into effector and memory lineages, it has been difficult 
to dissociate the contribution of antigen and costimulation signals 
(signal 1 and 2) from inflammatory cytokines (signal 3) to this 
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were digested with DNase and Collagenase for 20 min at 37°C/7% 
CO
2
 with shaking (120 RPM). Spleen pieces were smashed through 
a nylon cell strainer (70 μm) to generate a single cell suspension, 
red blood cells (RBC) were lysed and splenocytes were resuspended 
in two parts of 10% FCS RPMI-1640 to one part B16-Flt3L condi-
tioned medium + rGM − CSF (1000 μ/ml) + 2 μM Ova
257–264
 and 
incubated 2 h at 37°C/7% CO
2
 with shaking (100 RPM). Spleen 
cells were washed three times and CD11c+ cells were isolated using 
anti-CD11c microbeads (Miltenyi Biotec, Auburn, CA, USA). The 
purity and activation status of DC were determined by staining 
for CD11c, CD86, and MHC class II. Routinely, greater than 90% 
pure CD11c+ DC were obtained and the yield was approximately 
15–20 × 106 DC per mouse. DC were resuspended in saline and 
injected i.v.
BacterIa
actA-deficient L. monocytogenes expressing Ova
257–264
 (attLM-Ova) 
were grown, injected ∼5 × 106 cfu i.v. per mouse for boosting and 
quantified as described (Badovinac et al., 2005).
adoptIve-transfer experIments
Wild-type (WT) (Thy1.1/1.2) and receptor-deficient OT-I cells 
(Thy1.2/1.2) both (CD45.2) were obtained from the spleen of naïve 
donors. IFNABR−/− and IL-12Rβ1−/− OT-I cells were kindly provided 
by Dr. Matthew Mescher (University of Minnesota, Minneapolis, 
MN, USA). Spleens of transgenic donor mice were obtained fresh 
within 24 h of the day of adoptive-transfer experiment and RBC 
were removed with lysis buffer. To ensure the naïve status, OT-I 
transgenic cells were isolated fresh and were not in in vitro culture. 
Frequency of OT-I transgenic cells were determined by staining 
for CD8, Vα2, Vβ5, and analyzed with FACS. The number of input 
OT-I was calculated from the total number of splenocytes and the 
frequency of OT-I transgenic cells determined via FACS. Based on 
the number of input OT-I calculated, the WT (Thy1.1/1.2) and 
receptor-deficient OT-I cells (Thy1.2/1.2) both (CD45.2) were 
mixed and the ratio (WT:receptor-deficient OT-I) was checked via 
FACS prior to transfer into naive CD45.1 B6 mice (Badovinac et al., 
2007). Approximately 600 WT OT-I and 600 receptor-deficient OT-I 
were co-transferred to each recipient CD45.1 mouse. All mice were 
immunized with ∼1 × 106 Ova257-coated matured DC at day 0 with 
or without CpG 1826 (IDT, Iowa City, IA, USA; 100 μg i.p.).
GeneratIon of radIatIon Bone marrow chImerIc mIce
Bone marrow cells were obtained from tibia and femurs from 
naïve WT B6 (Thy1.1, CD45.2) and receptor-deficient B6 (Thy1.2, 
CD45.2) mice. Following removal of RBC, approximately 5 × 106 
WT cells and 5 × 106 receptor-deficient cells were mixed and trans-
planted to each lethally irradiated (90 Gy) CD45.1 recipient mouse. 
Reconstitution of donor lymphocytes was verified by flow cytom-
etry at 8 weeks following transplantation. All experiments were 
carried out after 8 weeks of reconstitution.
QuantIfIcatIon and phenotypIc analysIs of antIGen-specIfIc  
t cells
The magnitude of the epitope-specific CD8 T cell response was 
determined either by tetramer staining as described (Badovinac 
et al., 2002) or by staining for the CD45.2 marker that is exclusively 
 immunization (Badovinac et al., 2005). In contrast, the acquisition 
of phenotypic and functional memory characteristics by CD8 T 
cells takes several months after clearance of acute infection (Kaech 
et al., 2002a). Consistent with this, DC immunization in the pres-
ence of CpG-induced inflammation also delayed memory CD8 T 
cell development (Badovinac et al., 2005). Therefore, inflammatory 
cytokines promote and sustain the effector differentiation program 
and prevent the early acquisition of memory characteristics by the 
responding CD8 T cells (Pham et al., 2009). Thus, the DC immuni-
zation model in the presence or absence of inflammation allows us 
to specifically address whether the specific inflammatory cytokines, 
type I IFNs, or IL-12, signaling to the responding antigen-specific 
CD8 T cells, not only enhance effector cell commitment but also 
directly regulate the effector/memory differentiation program.
Here, we show that both type I IFN and IL-12 serve as signal 
3 cytokines to promote optimal CD8 T cell expansion after DC 
immunization in the presence of CpG-induced systemic inflamma-
tion. However, neither cytokine receptor on CD8 T cells is essen-
tial for inflammation-induced effector commitment. Thus, these 
results show that the role of Type I IFN and IL-12 as signal 3 during 
expansion can be dissociated from the signal(s) that regulate the 
CD8 T cell effector/memory differentiation program.
materIals and methods
mIce
C57BL/6 (CD45.1) mice were obtained from the National Cancer 
Institute (Frederick, MD, USA). B6.PL-Thy1a/CyJ (Thy1.1) and 
IL-12Rβ2−/− mice were obtained from the Jackson Laboratory (JAX). 
OT-I and IFNABR−/− mice were previously described (Hogquist 
et al., 1994; Kolumam et al., 2005). IFNABR−/− and IL-12Rβ1−/− OT-I 
cells were kindly provided by Dr. Matthew Mescher (University of 
Minnesota, Minneapolis, MN, USA). Experiments were conducted 
according to federal and institutional guidelines and approved by 
the University of Iowa Animal Care and Use Committee (Iowa 
City, IA, USA).
antIBodIes, peptIdes, and mhc class I tetramers
Antibodies of the indicated specificity with appropriate fluoro-
chromes were used. The following antibodies were from eBioscience 
(San Diego, CA, USA): IFN-γ (XMG1.2), CD8 (53–6.7), CD127 
(A7R34), KLRG-1 (2F1), CD11c (N418), CD86 (GL-1), MHC II 
(I-A/I-E; M5/114.15.2), (CD45.1 (A20), CD45.2 (104) isotype 
control rat IgG2a (eBR2a), rat IgG2b (KLH/G2b-1-2), Armenian 
Hamster IgG, and Golden Syrian Hamster IgG. The following anti-
bodies were from BD Pharmingen (San Diego, CA, USA): CD11c 
(HL3), Thy1.1 (OX-7). The following antibodies were from Caltag 
(San Diego, CA, USA): anti-human Granzyme B and isotype con-
trol mouse IgG1. MHC class I tetramers (Kb) specific for Ova
257–264
 
prepared using published protocols.
dendrItIc cells
Splenic DC were prepared as previously described (Pham et al., 
2009). In brief, splenic DC were isolated after subcutaneous injec-
tion of B6 mice with 5 × 106 B16 cells expressing Flt3L (provided by 
M. Prlic and M. Bevan, University of Washington). When tumors 
were palpable (5 mm × 5 mm), mice were injected with 2 μg LPS 
(Sigma) i.v. to mature the DC. Spleens were harvested 16 h later and 
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both type I IFN and IL-12 as the signal 3 for optimal CD8 T cell 
expansion after DC immunization in the presence of CpG-induced 
inflammatory cytokines.
neIther type I Ifn nor Il-12 dIrect sIGnalInG In cd8 t cells Is 
reQuIred for effector dIfferentIatIon
Dendritic cells immunization in the absence of systemic inflam-
mation accelerates the memory differentiation in antigen-specific 
CD8 T cells (Badovinac et al., 2005). However, co-injection of CpG 
1826 induces systemic inflammatory cytokines that sustain effector 
CD8 T cell differentiation and prevent the accelerated progres-
sion to memory after DC immunization (Badovinac et al., 2005). 
These findings strongly suggest that inflammatory cytokines regu-
late memory CD8 T cell development. In addition, the ability of 
CpG to induce both IL-12p70 and IFN-αβ has been described 
(Krieg, 2002). Thus, DC immunization in the presence or absence 
of CpG-induced systemic inflammatory cytokines offers a unique 
opportunity to determine the direct role of type I IFN or IL-12 
signaling in regulating effector/memory CD8 T cell differentia-
tion in vivo.
To address this question, we examined the phenotype of WT and 
receptor-deficient Tg OT-I cells from the peripheral blood at day 
7 following Ova
257
-coated DC immunization ± CpG. Consistent 
with previous findings, a substantial fraction of OT-I cells respond-
ing to DC immunization exhibited a memory-like phenotype 
(CD127hiKLRG-1lo) at day 7 after immunization (Badovinac et al., 
2005; Pham et al., 2009). This was true for both WT and IFNABR−/− 
OT-I or WT and IL-12Rβ1−/− OT-I cells responding in the same host 
(Figures 2A–C). As previously shown, most WT OT-I cells respond-
ing to DC immunization in the presence of systemic inflammation 
(DC + CpG) displayed an effector phenotype (CD127loKLRG-1hi) 
at day 7 after immunization. Interestingly and in contrast to the 
clear impact that the absence of IFNABR or IL-12Rβ1 had on OT-I 
expansion in this model, IFNABR−/− OT-I, or IL-12Rβ1−/− OT-I cells 
clearly down-regulate CD127 and up-regulate KLRG-1 expression 
in the presence of CpG-induced inflammation (Figures 2A–C). 
To ensure that the phenotypic differences between the DC and 
DC + CpG groups that we observed truly reflect the effector/mem-
ory differentiation process, we analyzed the kinetics of CD127 and 
KLRG-1 expression from day 5 to day 7 following DC immuniza-
tion (Figures 2D,E). In the absence of CpG-induced inflamma-
tion, both WT and IFNABR−/− OT-I cells (Figure 2D, left panels) 
or WT and IL-12Rβ1−/− OT-I cells. (Figure 2E, left panels) quickly 
re-acquire CD127 expression and only a small fraction of these cells 
expresses KLRG-1 from day 5 to day 7 following DC immunization. 
In sharp contrast, both WT and IFNABR−/− OT-I cells (Figure 2D, 
right panels) or WT and IL-12Rβ1−/− OT-I cells. (Figure 2E, right 
panels) do not up-regulate CD127 expression and increasing fre-
quencies of these cells express KLRG-1 from day 5 to day 7 follow-
ing DC immunization in the presence CpG-induced inflammatory 
cytokines. Thus, OT-I cells that could not receive type I IFN or 
IL-12 signals during expansion still acquired an effector phenotype 
(CD127loKLRG-1hi) that was indistinguishable from WT OT-I cells 
in the same host. Hence, although both are required as signal 3 for 
optimal expansion in this model, neither type I IFN nor IL-12 serves 
as an essential signal to promote and sustain effector differentiation 
by the responding CD8 T cells.
expressed on transferred TCR-tg cells (Badovinac et al., 2007). In 
the experiments with bone marrow chimeric mice, staining for 
CD45.1 was used to distinguish between donor and recipient cells. 
Differential expression of Thy1.1 and Thy1.2 allowed separation of 
WT and receptor-deficient TCR-tg cells or transplanted cells. For 
analysis of circulating TCR-tg T cells, ∼50 μl of blood was obtained 
from each mouse. The number of Tg OT-I cells or antigen-specific 
CD8 T cells was presented as frequency of total PBL. For pheno-
typic analysis, blood was pooled from all mice in either DC only 
or DC + CpG immunization groups for OT-I cells or analyzed 
individually for bone marrow chimeric mice.
results
dIrect sIGnalInG By sIGnal 3 Inflammatory cytokInes, type I 
Ifn, or Il-12, to cd8 t cells promotes theIr expansIon after 
dc + cpG dna ImmunIzatIon
The requirement of direct type I IFN or IL-12 signaling for opti-
mal CD8 T cell expansion depends critically on the inflammatory 
cytokines produced by the specific pathogen in the study (Aichele 
et al., 2006; Thompson et al., 2006; Xiao et al., 2009). The role 
of these cytokines in supporting CD8 T cell expansion in vivo in 
response to DC immunization in the presence of CpG-induced 
inflammation has not been well established. To control for the 
potential variations in antigen load and inflammatory environ-
ment, we examined receptor-sufficient and receptor-deficient Tg 
OT-I cell responses in the same host (Figure 1A). Prior to adoptive 
transfer, the ratio of WT and receptor-deficient OT-I was moni-
tored by flow cytometry to ensure approximately equal numbers 
of each type were being transferred (Figures 1B,C). WT (WT)- 
and IFNABR−/−- and IL-12Rβ1−/− (not shown)-OT-I T cells exhibit 
similar naïve phenotypes (CD127hi and KLRG-1lo; Figure 1D). To 
approximate endogenous precursor frequencies (Blattman et al., 
2002; Badovinac et al., 2007), 600 WT (CD45.2; Thy1.1/1.2) and 600 
of either IFNABR−/− or IL-12Rβ1−/− (CD45.2; Thy1.2/1.2) naïve OT-I 
cells were co-transferred into congenic (CD45.1) hosts (Figure 1A). 
Mice were then immunized with Ova
257
-coated DC and CpG 1826 
(a TLR9 agonist) to induce systemic inflammatory cytokines. We 
then tracked the frequency of OT-I cells in blood during the pri-
mary expansion from day 5–7 after DC immunization by analyzing 
the CD8+ CD45.2+ cell populations and distinguishing WT and 
receptor-deficient OT-I cells by Thy1.1 staining (Figure 1E).
OT-I cells deficient for either type I IFN- or IL-12-receptor 
did not expand as robustly as their WT counterparts following 
DC immunization in the presence of CpG-induced inflammation 
(Figure 1F). Furthermore, the differences in CD8 T cell numbers 
between WT and receptor-deficient OT-I were more pronounced 
at day 6 and 7 compared to day 5 following immunization. These 
results are consistent with the notion that direct type I IFN or IL-12 
signaling to CD8 T cells both provide critical survival signals for 
their accumulation during the proliferative expansion phase after 
DC immunization in the presence of CpG-induced inflammation 
(Curtsinger et al., 2005; Aichele et al., 2006; Pearce and Shen, 2007). 
Interestingly, the expansion defect was apparent earlier and was 
slightly more severe for IL-12β1−/− OT-I cells than IFNABR−/− OT-I 
cells when compared to WT OT-I cells (Figure 1F), suggesting a 
more prominent role of IL-12 as the survival signal in this model 
(Cui et al., 2009). These results demonstrate an important role for 
Frontiers in Immunology | T Cell Biology  February 2011 | Volume 2 | Article 4 | 4
Pham et al. Inflammatory cytokines regulate CD8 T cell differentiation
 antigen-specific CD8 T cell response in chimeric mice contain-
ing both cytokine receptor-sufficient and receptor-deficient CD8 
T cells (Figure 3A).
Chimeric mice were immunized with Ova
257
-coated DC in the 
presence or absence of CpG-induced inflammation. Following DC 
immunization, Ova
257
-specific, receptor-deficient, and -sufficient 
CD8 T cell populations can be easily distinguished by Thy1.2 stain-
ing on the CD45.1-negative, Ova-tetramer positive CD8 T cells 
in the same mouse (Figure 3B). Both WT and IFNABR−/− Ova
257
-
specific CD8 T cells responding to DC immunization exhibited 
an accelerated memory phenotype (CD127hiKLRG-1lo) at day 7 
(Figure 3C). In contrast, both WT and IFNABR−/− Ova
257
-specific 
CD8 T cells displayed an effector phenotype (CD127loKLRG-1hi) 
Our results differ from a recent study showing that the lack 
of direct IL-12 signaling promotes CD127hiKLRG-1lo pheno-
type on the responding CD8 T cells in the presence of CpG-
induced inflammation (Cui et al., 2009). This discrepancy may 
be explained by the use of different transgenic CD8 T cells (OT-I 
vs P14), experimental approach, or the quality and quantity of 
inflammatory cytokines induced by CpG 1826 in the studies. 
We have observed that varying doses of CpG 1826 had differen-
tial effect on CD127 and KLRG-1 expression on the responding 
CD8 T cells (data not shown). In addition, the different results 
may arise from evaluating WT and receptor-deficient TCR-tg 
cells in the same (our study) or in different hosts (Cui et al., 
2009). To address this issue, we investigated the polyclonal 
FIgure 1 | Type I IFN and IL-12 serve as “signal 3” to promote optimal 
CD8 T cell expansion. (A) Experimental design: Naïve CD45.2 mice received 
600 naïve WT OT-I (Thy1.1)+ ∼600 receptor-deficient OT-I (CD45.1, Thy1.2) cells 
and were immunized with ∼1 × 106 Ova257-264-coated DC (i.v.) + CpG (100 μg i.p.) 
1 day later. The ratio of WT and (B) IFNABR−/− or (C) IL-12Rβ1−/− OT-I cells prior 
to transfer is shown. (D) Representative profiles of CD127 and KLRG-1
expression on naïve WT or IFNABR−/− OT-I cells prior to adoptive transfer. 
(e) Representative gating strategy to distinguish between WT and 
receptor-deficient OT-I cells. (F) WT and receptor-deficient OT-I responses 
from day 5 to day 7 after DC + CpG immunization expressed as frequency 
(mean ± SEM, n = 4) of OT-I cells in PBL. Data are representative of three 
independent experiments.
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acquisition of effector phenotype in the presence of CpG-induced 
inflammation. Taken together, these results suggested that other yet 
to be identified inflammatory cytokine(s) could fulfill this function 
or that there is a redundancy in inflammatory cytokine signaling 
to promote and sustain effector differentiation of the responding 
CD8 T cells.
functIonal effector/memory dIfferentIatIon of cd8 t cells Is 
Independent of type I Ifn or Il-12
Previous work in our lab demonstrated that the (CD127hiKLRG-1lo) 
phenotype correlated well with the ability of the DC-stimulated 
memory-like CD8 T cells to expand vigorously to short-interval 
booster immunization (Badovinac et al., 2005). Therefore, we 
investigated the secondary response potential in chimeric mice 
following DC immunization with or without CpG co-injection. 
when primed in the presence of CpG-induced inflammation and 
similar results were obtained in WT/IL-12Rβ2−/− chimeric mice 
(Figure 3C). DC immunization alone promoted early acquisition 
of a memory phenotype (CD127hiKLRG-1lo) while CpG-induced 
inflammation resulted in effector phenotype (CD127loKLRG-
1hi) by both WT and IL-12Rβ2−/− Ova
257
-specific CD8 T cells at 
day 7 (Figure 3C). Moreover, the difference in inflammation-
induced CD127 downregulation and KLRG-1 upregulation on 
both  receptor-sufficient and receptor-deficient Ova
257
-specific 
CD8 T cells was statistically significant when compared with DC 
immunization alone (Figures 3D,E). Importantly, these data with 
polyclonal, endogenous Ova
257
-specific CD8 T cells recapitulate 
the earlier data obtained for TCR-tg OT-I CD8 T cells. Thus, we 
conclude that direct signaling by either type I IFN or IL-12 in the 
responding CD8 T cells was not an absolute requirement for the 
FIgure 2 | Neither type I IFN nor IL-12 direct signaling to CD8 T cells is required 
for acquisition of effector phenotype. Experiment design is in Figure 1. PBL were 
pooled from mice in either DC or DC + CpG immunization groups for analysis. 
(A) Representative histograms showing CD127 and KLRG-1 expression on WT, 
IFNABR−/−, and IL-12Rβ1−/− OT-I cells at day 7 following priming. Gray histograms 
represent isotype controls. Numbers indicate percentage of OT-I positive for the 
indicated marker. Cumulative data from two independent experiments showing 
frequency of WT, IFNABR−/−, and IL-12Rβ1−/− OT-I expressing (B) CD127 and (C) 
KLRG-1 at day 7 following DC immunization in the presence or absence of CpG. 
Kinetics of CD127 and KLRG-1 expression by (D) WT and IFNABR−/− OT-I cells and 
(e) WT and IL-12Rβ1−/− OT-I cells from day 5 to day 7 following DC immunization in 
the presence or absence of CpG. Data are from two independent experiments.
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DC immunization (Figures 4A,B, filled squares). In contrast, total 
Ova
257
-specific CD8 T cells in both chimeric mice groups receiving 
DC + CpG failed to further expand in response to day-7 booster attLM-
Ova infection, reflecting their effector phenotype (CD127loKLRG-1hi; 
Figures 4A,B, open circles). Importantly, this short-interval booster 
infection resulted in higher frequency of total Ova
257
-specific memory 
CD8 T cells 43 days later in both sets of chimeric mice when they were 
primed in the absence of inflammation compared to priming in the 
presence of CpG-induced inflammation (Figures 4A,B).
The day-7 booster infection following DC priming resulted in 
increased secondary expansion for both WT and IL-12Rβ2−/− Ova
257
-
specific CD8 T cells following DC immunization only in the absence 
of CpG (Figure 4C). Similar results were obtained for WT and 
IFNABR−/− Ova
257
-specific CD8 T cells (Figure 4D). Interestingly, 
DC primed IL-12Rβ2−/− Ova
257
-specific CD8 T cells did not expand 
A booster immunization with actA-deficient L. monocytogenes 
expressing Ova
257-264
 epitope (attLM-Ova) was administered to the 
chimeric mice at day 7 following DC-Ova ± CpG DNA immuniza-
tion. We reasoned that if either type I IFN or IL-12 signaling in the 
antigen-specific CD8 T cells is critical in promoting their effector 
differentiation, CD8 T cells lacking either receptor would function 
more like accelerated memory cells when primed in the presence 
of CpG-induced inflammation and undergo more robust second-
ary expansion compared to the receptor-sufficient CD8 T cells in 
response to day-7 booster immunization with attLM-Ova.
Consistent with their memory phenotype (CD127hiKLRG-1lo), 
total Ova
257
-specific CD8 T cells (including both WT and receptor-
deficient cells) in both WT/IL-12Rβ2−/− and WT/IFNABR−/− chimeric 
mice groups that received DC immunization alone underwent sub-
stantial responses to booster infection with attLM-Ova at day 7 after 
FIgure 3 | Acquisition of effector phenotype is independent of type I IFN 
receptor or IL-12 receptor signaling in polyclonal antigen-specific CD8 T cell 
response. (A) Experimental design: WT CD45.1 C57BL/6 mice were lethally 
irradiated and reconstituted with 1:1 mixture of either WT (CD45.2, Thy1.1) and 
IFNABR−/− (CD45.2, Thy1.2) or WT (CD45.2, Thy1.1) and IL-12Rβ2−/− (CD45.2, 
Thy1.2). Mixed bone marrow chimeric mice were allowed to reconstitute for at 
least 8 weeks before experiments were performed. (B) Representative gating 
strategy to distinguish between WT and receptor-deficient Ova257-specific CD8 T 
cells in bone marrow chimeric mice. Representative histograms (C) and 
cumulative data (D,e) showing CD127 and KLRG-1 expression on WT, 
IFNABR−/−, and IL-12Rβ2−/− Ova257-specific CD8 T cells at day 7 following DC or 
DC + CpG immunization. Gray histograms represent isotype controls. Statistical 
analysis was performed with student’s t-test between DC and DC + CpG 
groups. Data are representative of two independent experiments.
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nificantly higher number of WT memory CD8 T cells at day 43 
post  boosting compared to the IL-12Rβ2−/− memory CD8 T cells. 
This result possibly reflects the diminished capacity of IL-12Rβ2−/− 
Ova
257
-specific CD8 T cells to accumulate following booster immu-
nization, suggesting for the first time an important role of direct 
IL-12 signaling to promote optimal CD8 T cell expansion during 
as robustly as their WT counterparts following booster infection 
25× to 5×, respectively (Figure 4C, left side) while there was no 
statistically significant difference in fold expansion between WT 
and IL-12Rβ2−/− Ova
257
-specific CD8 T cells in the DC + CpG group 
(Figure 4C, right side). The difference in fold expansion between 
WT and IL-12Rβ2−/− Ova
257
-specific CD8 T cells resulted in sig-
FIgure 4 | Neither type I IFN nor IL-12 signaling is required to inhibit 
accelerated memory differentiation in the presence of Cpg-induced 
inflammation. WT/IFNABR−/− or WT/IL-12Rβ2−/− chimeric mice were 
immunized with ∼1 × 106 Ova257-264-coated DC ± CpG (100 μg i.p.) and were 
boosted with attLM-Ova 7 days later. Ova257-specific CD8 T cell response 
expressed as frequency (mean ± SEM, n = 6–8, data are posted from two 
independent experiments) in total PBL from (A) DC or (B) DC + CpG groups. 
Fold expansion/reduction = frequency of Ova257-specific CD8 T cells in PBL at 
day 6 post booster infection/frequency prior to booster infection (day 7 post 
DC immunization) for (C) WT/IFNABR−/− and (D) WT/IL-12Rβ2−/− chimeric mice. 
Frequency of Ova-specific CD8 T cells in the PBL at d43 after attLM-Ova boost 
in (e) WT/IL-12R2−/− and (F) WT/IFNABR−/− chimeric mice.
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These results were consistent with previous  publication showing 
that lack of IL-12 signaling on CD8 T cells favors the development 
of primary memory CD8 T cells with central memory phenotype 
(Pearce and Shen, 2007). Furthermore, IL-12 signaling on respond-
ing CD8 T cells has been shown to positively regulate T-bet expres-
sion (Takemoto et al., 2006) and T-bet-deficient mice enhanced the 
generation of antigen-specific CD8 T cells with central memory 
phenotype (Intlekofer et al., 2007).
In addition and consistent with published reports (Badovinac 
et al., 2003; Wherry et al., 2003; Jabbari and Harty, 2006), secondary 
memory CD8 T cells were slower to acquire central memory pheno-
type compared to primary memory CD8 T cells (Figure 5B). Lower 
frequencies of secondary memory CD8 T cells expressed CD62L 
and higher frequencies expressed KLRG-1. This was true for both 
WT and IL-12Rβ2−/− Ova
257
-specific memory CD8 T cells, although 
IL-12Rβ2−/− cells consistently had higher frequency expressing CD62L 
and lower frequency expressing KLRG-1 compared to WT cells in 
either primary or secondary memory populations (Figure 5B). Taken 
together, these results suggested that direct IL-12 signaling to antigen-
specific CD8 T cells clearly influences, but is not required for optimal 
generation of stable, long-term memory CD8 T cell populations. In 
addition, the lack of IL-12 signaling accelerates the development of 
central memory phenotype by antigen-specific CD8 T cells. However, 
IL-12 signaling does not significantly impact the memory phenotype 
between primary and secondary memory populations.
dIscussIon
Following activation by professional antigen presenting cells, 
antigen-specific CD8 T cells undergo a programmed response of 
proliferation, acquisition of effector functions, and formation of 
memory cells (Bevan and Fink, 2001; Kaech and Ahmed, 2001; van 
Stipdonk et al., 2001; Badovinac and Harty, 2006). Furthermore, the 
inflammatory environment in which the CD8 T cells are primed 
regulates multiple aspects of their response including expansion and 
effector and memory differentiation (Kaech et al., 2002b; Mescher 
et al., 2006; Harty and Badovinac, 2008). However, the “inflam-
matory signature” is often pathogen specific. The same is likely 
true for different immunostimulatory agents (i.e., adjuvants) used 
in vaccination protocols to generate a strong immune response. 
Thus, understanding the inflammatory mediator(s) that potentially 
regulate the effector and memory CD8 T cell differentiation would 
benefit vaccine design. Among the inflammatory cytokines, IL-12, 
type I IFNs, and IFN-γ have been studied most extensively in the 
CD8 T cell differentiation in various infection models and in vitro 
stimulation (Mescher et al., 2006).
The critical role of direct signaling by IL-12 and/or type I IFNs 
in the responding CD8 T cells to optimize their survival during the 
expansion phase has been well documented (Curtsinger et al., 2005; 
Kolumam et al., 2005; Pearce and Shen, 2007; Cui et al., 2009; Xiao 
et al., 2009). However, the role of these cytokines in the regulating of 
the balance between CD8 T cell effector and memory differentiation 
and maintenance in vivo still remains less well characterized. Here we 
analyzed with DC immunization ± CpG DNA to dissociate the role 
of type I IFN and IL-12 receptor signaling as the survival “signal 3” 
during expansion from the signal(s) that are required to regulate the 
CD8 T cell effector/memory differentiation program. Both type I IFN 
and IL-12 signaling to antigen-specific CD8 T cells are required for the 
secondary responses. On the other hand, we did not observe any 
statistically significant differences in fold expansion, fold reduction, 
or frequency of memory cells between WT and IFNABR−/− Ova
257
-
specific CD8 T cells at day 6 and day 43 post booster infection 
(Figures 4D–F). Taken together, these results suggest that neither 
type I IFN nor IL-12 signaling to the CD8 T cells was required for 
secondary memory development. However, IL-12 appears to play a 
more critical role for optimal secondary expansion of memory CD8 
T cells after short-interval attLM-Ova boosting.
lack of Il-12 sIGnalInG accelerates the development of 
central memory phenotype In Both prImary and secondary 
antIGen-specIfIc memory cd8 t cells
Up to this point, our results suggested that the absence of IL-12 sig-
naling did not prevent the Ova
257
-specific CD8 T cells from acquir-
ing effector phenotype (CD127loKLRG-1hi) or function (failing to 
boost) when primed in the presence of CpG-induced systemic 
inflammation. However, the impact of IL-12 signaling on number 
and phenotype of antigen-specific memory CD8 T cells between 
primary and secondary response was not entirely clear. Following 
booster immunization, we observed significant differences in both 
the fold expansion (day 6) and memory frequency (day 43) between 
WT and IL-12Rβ2−/− Ova
257
-specific CD8 T cells (Figures 4C–E). 
We, thus, decided to analyze in detail the Ova
257
-specific memory 
CD8 T cells and their phenotype following attLM-Ova infec-
tion only (primary response) or DC priming followed by day-7 
attLM-Ova booster infection (secondary response) at a long-term 
memory time point in WT/IL-12Rβ2−/− chimeric mice. Consistent 
with our earlier results, the number of IL-12Rβ2−/− Ova
257
-specific 
memory CD8 T cells was significantly lower than their WT coun-
terparts in both primary (attLM-Ova infection only) and secondary 
(DC + attLM-Ova) responses (Figure 5A). The lower number of 
IL-12Rβ2−/− Ova
257
-specific memory CD8 T cells reflected the criti-
cal role of IL-12 as a survival signal for antigen-specific CD8 T cells 
during expansion following priming with attLM-Ova. In addition, 
our results indicated that IL-12 signaling in antigen-specific CD8 
T cells is not required for either primary or secondary memory 
generation. We could readily detect IL-12Rβ2−/− Ova
257
-specific 
memory CD8 T cells at more than 100 days following either pri-
mary or secondary responses, albeit at a lower number compared 
to the WT cells (Figure 5A).
Phenotypic analysis of these stable WT and IL-12Rβ2−/− Ova
257
-
specific memory CD8 T cells in the WT/IL-12Rβ2−/− chimeric mice 
revealed interesting differences. In both primary memory popu-
lations (attLM-Ova only) and secondary memory populations 
(DC + attLM-Ova) at more than 100 days post priming, IL-12Rβ2−/− 
Ova
257
-specific CD8 T cells exhibited markedly different CD127, 
KLRG-1, and CD62L expression patterns. In primary memory pop-
ulation (attLM-Ova only), CD127 expression was not statistically 
different between WT and IL-12Rβ2−/− Ova
257
-specific CD8 T cells 
(Figure 5B, left panel). However, in the absence of IL-12 signaling, 
a higher frequency of the memory CD8 T cells expressed lymph 
node homing molecule CD62L and a lower frequency of these cells 
expressed KLRG-1. Thus, the lack of IL-12 signaling in these anti-
gen-specific CD8 T cells resulted in them possessing a more central 
memory phenotype (CD127hiCD62LhiKLRG-1lo) when compared 
directly to the corresponding WT cells in the same host (Figure 5B). 
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In addition, our study does not rule out the possibility that type I 
IFN and/or IL-12 are important in regulating the expression of other 
pro-inflammatory molecules that signal directly in CD8 T cells and 
control their differentiation. Alternatively, multiple inflammatory 
cytokines potentially serve a redundant role to enforce the effector 
CD8 T cell differentiation program. Thus, elucidating the signal(s) 
that regulate CD8 T cell memory differentiation remains a potential 
exciting strategy to manipulate memory generation and enhance 
protective immunity.
The role of direct IL-12 signaling in CD8 T cells has been exten-
sively studied in primary responses (Mescher et al., 2006). However, 
less is known about its role in secondary responses. Our model of DC 
priming followed by short-interval booster immunization allowed us 
to examine the secondary response post booster infection. Our results 
show that lack of direct IL-12 signaling in responding CD8 T cells 
impairs their expansion but did not prevent their acquisition of effec-
tor phenotype and function during the primary response. However, 
antigen-specific CD8 T cells that do not receive IL-12 signals acquire 
central memory phenotype (CD127hi, KLRG-1lo, and CD62Lhi) earlier 
than their WT counterparts in the same host. In particular, this is true 
for both primary response (LM infection) and secondary response (DC 
prime followed by LM boost). A recent publication from Mescher’s 
laboratory demonstrated that direct IL-12 signaling in CD8 T cells 
regulates chromatin remodeling and epigenetic modifications at mul-
tiple loci after in vitro stimulation (Agarwal et al., 2009). These results 
raise the possibility that IL-12-induced epigenetic modifications poten-
tially regulate the rate of central memory formation. However, it is still 
unclear at this point whether accelerated acquisition of central memory 
optimal expansion in the presence of CpG-induced systemic inflam-
mation since the lack of either receptor on CD8 T cells resulted in 
diminished expansion following DC + CpG immunization. However, 
neither type I IFN nor IL-12 signaling is required for CD8 T cell 
effector differentiation in the same immunization model. Using both 
adoptive transfer of transgenic CD8 T cells in the same host and mixed 
bone marrow chimeric mice, we demonstrated that direct signaling 
by either IL-12 or type I IFNs in the responding CD8 T cells was not 
required for their acquisition of effector phenotype and function.
A Recent publication by Xiao et al. (2009) showed that memory 
CD8 T cells lacking IL-12 receptors or type I IFN receptors are sig-
nificantly reduced following vaccinia or LM infection compared to 
their WT counterparts. It is still not entirely clear whether CD8 T 
cells lacking either IL-12 receptors or type I IFN receptors fail to dif-
ferentiate into memory population or their survival is compromised. 
Interestingly, however, the IL-12 requirement for memory develop-
ment is not absolute since WT and type I IFN receptor-deficient CD8 
T cells developed memory population following vaccinia infection in 
both IL-12p40- and IL-12p35-deficient mice (Xiao et al., 2009). These 
results suggested that the cytokine milieu of the host might play an 
important role in supporting memory development. Consistent with 
this notion, our results showed that the lack of IL-12 or type I IFN 
direct signaling on CD8 T cells did not promote accelerated memory 
differentiation in the presence of CpG-induced systemic inflamma-
tion. Since CpG induces various pro-inflammatory cytokines in addi-
tion to type I IFN and IL-12 (Krieg, 2002), it is possible that a yet to 
be identified pro-inflammatory cytokine serves as the critical signal 
that regulates the rate of CD8 T cell effector/memory differentiation. 
FIgure 5 | Lack of IL-12 signaling accelerates the development of central 
memory phenotype in both primary and secondary antigen-specific memory 
CD8 T cells. WT/IL-12Rβ2−/− chimeric mice were either immunized with ∼1 × 106 
Ova257-264-coated DC or nothing and they all received ∼5 × 106 cfu attLM-Ova 7 days 
later. (A) Total number of WT and IL-12Rβ2−/− Ova257-specific CD8 T cells per spleen 
was determined at day 108 after attLM-Ova challenge. (B) Frequency of WT and 
IL-12Rβ2−/− Ova257-specific CD8 T cells expressing CD127, KLRG-1, and CD62L at 
day 108 following attLM-Ova in both DC + LM or LM only groups.
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phenotype in the absence of direct IL-12 signaling results from the sub-
optimal expansion of CD8 T cells both in the primary and secondary 
response (Schluns and Lefrancois, 2003) or epigenetic modifications or 
both. Additional studies remain warranted to understand the complex 
regulation of CD8 T cell memory differentiation.
